The 7-year CIR and TRM (competing risk) according to the number of PT-LU HLA locus shared mismatches against the WU and considering patients with at least 2 HLA mismatches with the WU. With no PT-LU HLA shared mismatch against the WU (n = 146), the CIR was 29% (95% CI, 21-37) vs 29% (95% CI, 20-37) with a single PT-LU HLA shared mismatch (n = 127) vs 7% (95% CI, 0-15) with multiple PT-LU HLA shared mismatches (n = 46). With no PT-LU HLA shared mismatch against the WU, the TRM was 25% (95% CI, 18-32) vs 24% (95% CI, 17-32) with a single PT-LU HLA shared mismatch vs 34% (95% CI, 20-49) with multiple PT-LU HLA shared mismatches.